Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/04/2026 | Q4 | $234.8M | -- | -- | -$0.06 | -- |
| 11/05/2025 | Q3 | $235.7M | $241M | $0.19 | -$0.05 | $0.24 |
| 08/06/2025 | Q2 | $223.6M | $218.4M | -$0.15 | -$0.11 | -$0.05 |
| 05/07/2025 | Q1 | $222.2M | $226.5M | -$0.16 | -$0.20 | $0.04 |
| 03/05/2025 | Q4 | $222.8M | $236.3M | -$0.57 | -$0.11 | -$0.46 |
| 11/06/2024 | Q3 | $267.6M | $251.8M | -$0.04 | $0.05 | -$0.09 |
| 08/06/2024 | Q2 | $232.5M | $236.5M | -$0.05 | -$0.09 | $0.04 |
| 05/06/2024 | Q1 | $217.5M | $240.6M | -$0.17 | -$0.11 | -$0.06 |
| 03/11/2024 | Q4 | $292.8M | $273.6M | -$0.26 | -$0.12 | -$0.14 |
| 11/06/2023 | Q3 | $308.7M | $318.1M | -$0.05 | $0.10 | -$0.15 |
| 08/07/2023 | Q2 | -- | $317.3M | $0.10 | -- | -- |
| 05/08/2023 | Q1 | -- | $313.9M | -$0.18 | -- | -- |
| 03/09/2023 | Q4 | -- | $328.4M | -$0.46 | -- | -- |
| 11/07/2022 | Q3 | -- | $336.9M | -$0.39 | -- | -- |
| 08/08/2022 | Q2 | -- | $362.2M | $0.29 | -- | -- |
| 05/09/2022 | Q1 | -- | $308.1M | -$0.04 | -- | -- |
| 03/10/2022 | Q4 | -- | $385.5M | $0.49 | -- | -- |
| 11/09/2021 | Q3 | -- | $305.6M | -$0.05 | -- | -- |
| 08/03/2021 | Q2 | -- | $298.1M | $0.11 | -- | -- |
| 05/12/2021 | Q1 | -- | $218.7M | $0.06 | -- | -- |
| 03/10/2021 | Q4 | -- | $168.8M | -$0.30 | -- | -- |
| 11/09/2020 | Q3 | -- | $204.7M | $0.24 | -- | -- |
| 08/11/2020 | Q2 | -- | $212.1M | $0.27 | -- | -- |
| 05/12/2020 | Q1 | -- | $311.4M | -$0.47 | -- | -- |
| 03/26/2020 | Q4 | -- | $357.6M | -$0.85 | -- | -- |
| 11/07/2019 | Q3 | -- | $365.2M | -$0.58 | -- | -- |
| 07/31/2019 | Q2 | -- | $346.3M | -$0.17 | -- | -- |
| 05/01/2019 | Q1 | -- | $355.8M | -$0.29 | -- | -- |
| 03/12/2019 | Q4 | -- | $334.4M | -$0.74 | -- | -- |
| 10/31/2018 | Q3 | -- | $370.4M | -$0.18 | -- | -- |
| 08/08/2018 | Q2 | -- | $410.5M | -$0.31 | -- | -- |
| 05/08/2018 | Q1 | -- | $400M | -$0.19 | -- | -- |
| 02/28/2018 | Q4 | -- | $395.3M | -$0.32 | -- | -- |
| 11/07/2017 | Q3 | -- | $445.4M | -$0.01 | -- | -- |
| 08/02/2017 | Q2 | -- | $405.2M | -$0.22 | -- | -- |
| 05/10/2017 | Q1 | -- | $386.3M | -$0.31 | -- | -- |
| 03/01/2017 | Q4 | -- | $441.7M | $0.30 | -- | -- |
| 11/03/2016 | Q3 | -- | $417.8M | -$0.09 | -- | -- |
| 07/05/2016 | Q2 | -- | $422.9M | $0.11 | -- | -- |
| 03/31/2016 | Q1 | -- | $342.4M | -$0.32 | -- | -- |
| 03/10/2016 | Q4 | -- | -- | -- | -- | -- |
Alto Ingredients, Inc. reported $241M worth of top line sales in its most recent quarter.
Alto Ingredients, Inc. announced earnings per share of $0.19 which represents a beat of analyst forecast a -$0.05 per share.
Alto Ingredients, Inc. reported $29.3M that represents $0.39 per share over the last quarter.
Alto Ingredients, Inc.'s earnings are forecast to decrease from -$0.82 per share to -$0.36 per share next year representing a decrease of -78.05%.
Alto Ingredients, Inc.'s next earnings date is March 4, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.